Bretylium tosylate is a Class III antiarrhythmic agent that has historically been utilized in emergency medicine for the management of ventricular tachycardia and ventricular fibrillation when other first-line… Read more
Bretylium tosylate is a Class III antiarrhythmic agent that has historically been utilized in emergency medicine for the management of ventricular tachycardia and ventricular fibrillation when other first-line treatments, such as defibrillation or lidocaine, have proven ineffective. Its mechanism involves blocking potassium channels and modulating sodium influx to stabilize cardiac rhythm. This category provides essential reference standards, related impurities, metabolites, and stable isotope-labelled compounds necessary for rigorous analytical testing and quality control of this pharmaceutical substance. Pharmaceutical laboratories rely on these high-quality materials for impurity profiling, method validation, and accurate quantitation in complex matrices. By utilizing these precise standards, analysts can ensure compliance with regulatory pharmacopeial requirements and maintain the integrity of stability studies and developmental research workflows for this therapeutic agent.